Beijing Taisheng Pharmaceutical

Beijing Taisheng Pharmaceutical Co., Ltd., a subsidiary of Sinopharm Modern Pharmaceutical (part of the Sinopharm Group), is a specialized pharmaceutical company focused on the oncology and hematology sectors. Based in Beijing, the company is a leading manufacturer of anthracycline anti-tumor antibiotics in China, featuring a portfolio that includes Epirubicin, Idarubicin, and Pirarubicin. Taisheng operates high-standard GMP manufacturing facilities and serves as a core production hub for Sinopharm's oncology medications. The company's products are widely utilized in the treatment of various malignancies such as breast cancer and leukemia, and it maintains a significant presence in both domestic and international pharmaceutical markets.